CMS contracted Easton, Md.-based Health Integrity to investigate the $124 billion Medicare Advantage program, or Part C, and the prescription drug benefit, Part D. The OIG found 79 percent of Health Integrity’s nearly 2,300 fraud-finding investigations between 2010 and 2011 focused on Part D compared with 8 percent toward Part C.
Health Integrity shifted blame for its lopsided attention to CMS, which doesn’t grant the company access to Medicare Advantage’s central claims database to use for investigations, according to the report. Additionally, Health Integrity said unless law enforcement agrees to take on fraud cases, it lacks the authority to proceed with investigations.
More Articles on Medicare Advantage:
Commonwealth Fund: 10 Policies That Can Stabilize Healthcare Spending
District Court Orders HHS to Recalculate Medicare DSH Payments
Where Medicare Stands: A Discussion With Dr. Oliver Fein of Weill Cornell Medical College
